Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis

Figure 2

DAG 18:1 20:4 and 18:0 20:4 concentrations in plasma of patients with mastocytosis and healthy controls. DAG 18:1 20:4 (a) and DAG 18:0 20:4 (b) concentrations in healthy controls and mastocytosis patients. DAG 18:1 20:4 and DAG 18:0 20:4 concentrations in healthy females and males (c, d) and in mastocytosis females and males (e, f).

(a)

(b)

(c)

(d)

(e)

(f)